Could cousins be as good as siblings for stem cell donation?
NCT ID NCT07662382
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether using a cousin as a stem cell donor works as well as using a sibling for people with blood cancers. Researchers will compare survival, relapse, and side effects like graft-versus-host disease in patients who received a transplant from either a cousin or a sibling. The goal is to see if cousin donors can be a reliable option when a sibling is not available.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- haploidentical hematopoietic stem cell transplantation
- What this could lead to
- If cousin donors prove as good as siblings, it could expand the donor pool for stem cell transplants, helping more patients find a match.
- What could go wrong
- This is an observational study, not a controlled trial, so results may be influenced by other factors. It also looks at past data, which may not predict future outcomes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE LEUKEMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
The First Affiliated Hospital of Soochow University
Suzhou, Jiangsu, 215000, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could muscle loss predict blood cancer outcomes?
- A shot at safer CAR t: early brain protection for lymphoma patients?
- Can a gentler chemo prep make stem cell transplants safer for blood cancer patients?
- Talking about the end: could guided conversations reduce futile cancer treatments?
- A simple blood test may reveal hidden infertility risk in young cancer survivors
- Can a smart tool keep watch on leukemia after treatment stops?